Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Biden transition, U.S. coronavirus vaccine teams to meet amid surge, distribution questions

EconomyDec 06, 2020 03:05PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington

By Doina Chiacu

WASHINGTON (Reuters) - The chief adviser for U.S. efforts to develop a coronavirus vaccine said on Sunday he planned to meet with President-elect Joe Biden's team this week to discuss the program before the expected first round of vaccinations this month.

Moncef Slaoui, chief adviser to the U.S. government's Operation Warp Speed initiative, said he has not yet met with Biden, who last week criticized the Trump administration's vaccine distribution plan.

"We really look forward to it because actually things have been really very appropriately planned," Slaoui said in an interview with CBS' "Face the Nation."

Biden said on Friday his team had not seen a detailed outline from the Trump administration to distribute a vaccine to states, which he called an expensive and difficult process.

"There is no detailed plan that we've seen, anyway, as to how you get the vaccine out of a container, into an injection syringe, into somebody's arm," Biden said.

Slaoui said the government's plan relies on state health agencies to deliver the vaccine.

"I think the plans are there and I feel confident that once we will explain it, everything in detail. I hope the new transition team will understand that things are well planned," he told the CBS program.

It was not clear if Biden would attend the meeting himself.

The United States is struggling with a resurgence of the virus, with record infections and a daily death toll that has exceeded 2,000 in recent days. More than 281,000 Americans have died from the COVID-19 disease, according to a Reuters tally.

President Donald Trump's refusal to acknowledge his loss to Biden in the Nov. 3 presidential election caused a delay in the transition process that allowed White House health advisers to communicate with the new Biden health advisory team.

Biden was due to announce members of his public health team this week.

VACCINE MANUFACTURING DELAY

First-responders, health care workers and nursing home residents will be the first groups to receive the vaccine once the U.S. Food and Drug Administration approves it, which is expected in the next week or two. The FDA's outside advisers are scheduled to meet on Thursday to review Pfizer (NYSE:PFE)'s emergency use application for its vaccine.

FDA approval does not assure smooth sailing. Slaoui told CNN's "State of the Union" the vaccine manufacturing effort has been more complicated and difficult than expected.

"We probably are six or eight weeks later than an ideal scenario, where we had 100 million doses by the end of this year," he said. "But we are not far."

The people most susceptible to coronavirus would start seeing the impact of the vaccine in January or February, Slaoui said on CBS.

"But on a population basis, for our life to start getting back to normal, we're talking about April or May," he said.

With the winter holiday season approaching, U.S. health experts have been pleading with Americans to not let up on their coronavirus safety protocols - wearing masks, social distancing and avoiding large gatherings.

Dr. Deborah Birx, who serves on the White House coronavirus task force, told NBC's "Meet the Press" that public health officials have had to battle incorrect messages from the Trump administration about masks and other mitigation measures.

"I want to be very frank to the American people. The vaccine is critical. But it's not going to save us from the current surge," she said. "Only we can save us from this current surge."

Biden transition, U.S. coronavirus vaccine teams to meet amid surge, distribution questions
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (5)
Kelly Mayer
Kelly Mayer Dec 06, 2020 5:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Biden has to concede. He has no choice. And he will.
Julius Tsui
Julius Tsui Dec 06, 2020 4:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stop broadcasting FAKE NEWS. Biden is not the President yet! Wait for the official announcement. Is it people only care about USD up or down, making money? I could not understand you people! Money is not everything!!!!!!!!!!!!!!!!!!!!!!!!
New Jazenevd
New Jazenevd Dec 06, 2020 3:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Talking about viruses and vaccines, Biden will not do anything different from Trump. It is just possible to find something to do differently. Talking about investment and market, the only important political event ahead is Georgia races outcome in January.
Rushikesh Rithe Rushikesh Rithe
Rushikesh Rithe Rushikesh Rithe Dec 06, 2020 12:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vaccine hype!!
ICDO Balochistan
ICDO Balochistan Dec 06, 2020 9:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do u think? what will happen to dollor after this news.
Andrew Allen
Andrew Allen Dec 06, 2020 9:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nothing
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email